Drug Information PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Drug Information PDF full book. Access full book title Drug Information by Patrick M. Malone. Download full books in PDF and EPUB format.
Author: Patrick M. Malone
Publisher: McGraw Hill Professional
ISBN: 9780071492034
Category : Medical
Languages : en
Pages : 907
Get Book
Book Description
Extensive coverage of the Internet as a source of and distribution means for drug information, and detailed sections on evaluating medical literature from clinical trials Audience includes Pharmacists, Pharmacy students and Pharmacy schools Updated to include using PDAs for medication information Covers the ethical and legal aspects of drug information management Nothing else like it on the market
Author: Patrick M. Malone
Publisher: McGraw Hill Professional
ISBN: 9780071492034
Category : Medical
Languages : en
Pages : 907
Get Book
Book Description
Extensive coverage of the Internet as a source of and distribution means for drug information, and detailed sections on evaluating medical literature from clinical trials Audience includes Pharmacists, Pharmacy students and Pharmacy schools Updated to include using PDAs for medication information Covers the ethical and legal aspects of drug information management Nothing else like it on the market
Author:
Publisher: World Health Organization
ISBN: 9240047212
Category : Medical
Languages : en
Pages : 265
Get Book
Book Description
Author: Marie A. Abate
Publisher: Pharmaceutical Press
ISBN: 0857110667
Category : Medical
Languages : en
Pages : 225
Get Book
Book Description
A concise guide to medical literature evaluation and the provision of medication and health information.
Author: World Health Organization
Publisher: World Health Organization
ISBN: 924156301X
Category : Medical
Languages : en
Pages : 1526
Get Book
Book Description
The International Pharmacopoeia contains a collection of recommended methods for analysis and quality specifications for pharmaceutical substances, excipients and products. This new edition consolidates the texts of the five separate volumes of the third edition and includes new monographs for antiretroviral substances (didanosine, indinavir sulfate, nelfinavir mesilate, nevirapine, ritonavir, saquinovir, and saquinovir mesilate) adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2004. It includes some additions and amendments to the general notices of the Pharmacopoeia, as well as some changes to its layout and format. Volume one contains monographs for pharmaceutical substances A to O and the General Notices; and volume two contains monographs for pharmaceutical substances P to Z, together with those for dosage forms and radiopharmaceutical preparations, the methods of analysis and reagents.
Author: Michael Gabay
Publisher: Jones & Bartlett Publishers
ISBN: 128402623X
Category : Medical
Languages : en
Pages : 538
Get Book
Book Description
"This resource will educate students and pharmacists on traditional drug information topics while providing an extensive background on more recent practice areas. This is a user-friendly text with multiple examples that can be used in education and training, as well as clinical practice. Each chapter includes learning objectives, key terms, example
Author: Charles F. Lacy
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 1836
Get Book
Book Description
Author: Patrick M. Malone
Publisher: McGraw Hill Professional
ISBN: 1260460312
Category : Medical
Languages : en
Pages : 1630
Get Book
Book Description
Everything pharmacists and pharmacy students need to know about drug information management A Doody's Core Title for 2023! Drug Information: A Guide for Pharmacists provides you with the tools you need to to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible. This trusted resource addresses essential topics such as formulating an effective response and recommendations for information, evaluation of drug literature, the application of statistical analysis in the biomedical sciences, medications and patient safety, investigational drugs, and more. This updated seventh edition also addresses other important issues such as the legal and ethical considerations of providing information, how to respond to requests for information, and how to determine what information should be made available.
Author: WHO Expert Committee on the Selection and Use of Essential Medicines
Publisher: WHO
ISBN:
Category : Medical
Languages : en
Pages : 144
Get Book
Book Description
This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a progress report on the new procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues with a section on changes made in revising the Model List followed by a review of some sections such as hypertensive medicines and fast track procedures for deleting items. Annexes include the 13th version of the Model List and items on the list sorted according to their 5-level Anatomical Therapeutic Chemical classification codes.
Author: Charles Lacy
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 1650
Get Book
Book Description
Author: ASHP
Publisher:
ISBN: 9781585286843
Category : Medical
Languages : en
Pages : 0
Get Book
Book Description
AHFS Drug Information® 2022 contains the most dependable drug information available-all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice. Updates in the new edition: The latest information on COVID-19 vaccines and COVID-19 monoclonal antibodies available under FDA Emergency Use Authorizations (EUAs), including clinical considerations from the US Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH). Information on patient selection and appropriate use of corticosteroids in the management of COVID-19 based on recent guidelines from NIH and the World Health Organization (WHO). Contemporary issues such as anticoagulant reversal strategies and use of direct oral anticoagulants versus warfarin for treatment of venous thromboembolism or atrial fibrillation. Current best practices such as reversal of neuromuscular blocking agents for prevention of postoperative residual neuromuscular blockade. Newly published information on breakthrough oncology drugs approved as part of the FDA's accelerated approval program. Expanded content on off-label uses, real-world data, and long-term clinical data. Updated information on pharmacogenomic considerations based on recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Addition of 51 new molecular entities (NMEs) or new therapeutic biological products approved since January 2021.
